Crumbs from the System: The U.S. “UFO Disclosure” Is a Joke Compared to What Dakila Has Already Proven
BRASÍLIA, Brazil, June 01, 2026 (GLOBE NEWSWIRE) — The United States Department of Defense recently staged a major global media spectacle. The American government released an online repository filled with old
Ealixir Expands Media Presence Through Affaritaliani Regional Publishing Initiative
MIAMI, Fla., June 01, 2026 (GLOBE NEWSWIRE) — Ealixir Inc. (EAXR) (“Ealixir” or the “Company”), a digital identity infrastructure company specializing in online reputation management, is expanding its presence in
ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026
Analysis from the Phase 3 COMPETE trial suggests population-based modeling may enable accurate individualized dosimetry with substantially fewer imaging requirements Los Angeles, California, June 1, 2026 — ITM Isotope Technologies Munich
SKHTU Melancarkan Pelan Peningkatan Sistem Keselamatan, Menyusun Semula Aturan Kepercayaan dengan Teknologi Canggih
DENVER, June 01, 2026 (GLOBE NEWSWIRE) — Baru-baru ini, bursa SKHTU mengumumkan penyiapan peningkatan sistem perlindungan berbilang lapisan, dengan tumpuan pada pengukuhan mekanisme pengasingan storan sejuk, seni bina tandatangan berbilang,
Bitget Tackles Trading Burnout in New UEX Video Series
VICTORIA, Seychelles, June 01, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched “UEX Traders’ Secret,” a three-part video series that takes a humorous take on
Crypto Meets Wall Street: MEXC Unveils ‘RealStocks’ with 0-Fee U.S. Equity Trading and Real Dividends
MUTSAMUDU, Comoros, June 01, 2026 (GLOBE NEWSWIRE) — MEXC, a leading 0-fee cross-asset trading platform, today announced the official launch of ‘RealStocks.’ This innovative equity product is now accessible to
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development
Ruvi AI (RUVI) Introduces Staking in Its Latest Ecosystem Upgrade, Expanding Utility for Token Holders
DUBAI, United Arab Emirates, May 31, 2026 (GLOBE NEWSWIRE) — Markets are pricing roughly 97.5% odds of no rate cut at the upcoming Federal Reserve meeting, so the Fed is
CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization
BEIJING, May 31, 2026 (GLOBE NEWSWIRE) — This year marks the 70th anniversary of China-Africa relations. CGTN has published an article highlighting Africa’s priority role in China’s overall foreign policy,
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck
SlimTide Truth Revealed (2026 Official Website Risk Warning) Avoid Hidden Fees & Fake Complaints
Largo, FL, May 31, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. SlimTide is not intended to diagnose, treat, cure, or prevent
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with Pluvicto plus standard of care (ARPI + ADT) in PSMAddition Consistent secondary endpoint results, including PSA
Solana Unchained Outlines Fixed-Supply Utility Architecture and AI Tool Hub Ahead of Late May Public Allocation Launch
SACRAMENTO, Calif, May 30, 2026 (GLOBE NEWSWIRE) — Solana Unchained today disclosed the comprehensive operational structure of its upcoming decentralized platform, which unifies artificial intelligence features with three specialized infrastructure
Pompa Program Surpasses 1,300 Trustpilot Ratings with 4.7/5 Star Average
Los Angeles, CA , May 30, 2026 (GLOBE NEWSWIRE) — Pompa Program, a wellness coaching program, has surpassed 1,300 ratings on Trustpilot while holding a 4.7 out of 5-star average
GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – GOSS
NEW YORK, May 30, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June